The
Meteoric Rise Of Israel's TEVA Pharmaceutical Firm
The
Israelis Give American Investors The Chance To Invest
| |
 |
The Rarified World Of High
Finance
TEVA is based in Israel, but
is publicly traded on America's stock markets. It has a Market Capital
of $33 billion. All this company does is make generic drugs, which are
drugs developed by another company, and are coming off their patents.
|
| |
|
Take A Bottle Of Valium As
An Example
They crank it out in a
Mexican plant for 30 cents and an American pharmacy pays $12.00 for
it.
|
 |
| |
|
 |
But Here Is The Big Money
That
company is worth $33 billion on the
NASDAQ. And that $33 billion comes from your pension plans, and winds
up in a Zionist bigwig's pocket.
|
| |
|
Israel's Teva Buys US
Copycat Drug Rival For $7.5bn
The global leader in copycat
drug manufacture, Teva Pharmaceuticals, is taking over a US rival,
Barr Pharmaceuticals, in a $7.5 billion deal which continues a rapid
spate of consolidation in the crowded industry for generic medicines.
|
 |
| |
|
| |
|
|
|
How Does This Come About?
The answer lies in the world
of Sayanims. It is a world of Zionist inter-dependence, where a
Starbucks outlet can get an exclusive toll road plaza, airport space,
prime mall space, etc., but others can't get in the door.
|
|
|
| |
|
This Could Be An
Endless Article
An accountant would have a field day deciphering those books. An Israeli
company selling on a U.S. stock exchange?!? Where did TEVA come from?
Who are the owners?
This would be like debating if a Black Mamba could be a good pet. When
Mr. Mamba smiles, and says "Trust me, open the cage up", it will
be the biggest mistake of your life. The past 25 years of the entire
American stock market would be comical, if it wasn't the biggest swindle
in the history of the world.
The only survivors that will be
left standing will be those, holding physical possession of gold.
|
| |
No comments:
Post a Comment